Double materiality assessment

Our approach to material sustainability topics

We value the diverse perspectives of our key stakeholders, that help guide our sustainability strategy. We conduct regular materiality assessments to identify the issues that matter the most to AstraZeneca and our stakeholders and where we can have a positive impact.

Double materiality assessment

Our double materiality assessment complies with the EU Corporate Sustainability Reporting Directive requirements, identifying material sustainability-related risks and opportunities for AstraZeneca, and our impacts on people and the environment.